Kyverna Presents Registrational Trial Primary Analysis for Miv-cel in Stiff Person Syndrome Demonstrating Statistically Significant, Durable Clinical Benefit Across All Endpoints in an Oral, Late-Breaker Session at AAN Annual Meeting
Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability…
RNK Health NAD+ Longevity Therapy Claims Evaluated: The Clinician-Guided NAD Injections & Medication Protocol
Des Moines, IA, April 21, 2026 (GLOBE NEWSWIRE) -- The information below…
Revolution Medicines to Present Updated Phase 1/2 Clinical Data for Daraxonrasib in First Line Metastatic Pancreatic Cancer Across Monotherapy and Combination Cohorts at the 2026 AACR Annual Meeting
REDWOOD CITY, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc.…
AvePoint to Announce First Quarter 2026 Financial Results on May 7
JERSEY CITY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- AvePoint (Nasdaq: AVPT; SGX:…
NewHydrogen Completes Critical Pre-Pilot Plant Technical Validation
The Company greenlights construction of a ThermoLoop engineering test unit to define…
The System Missing Between Field Operations and Finance Is Here
A workforce operations platform built for complex field teams that captures, validates,…
Tredence Awarded 2026 Google Cloud Global Industry Solutions Partner of the Year Award for Retail
Trusted for driving the data & AI strategy for 8 of the…
CATL Unveils Six Major Innovations: Multi-Chemistry Systems to Redefine New Energy Mobility Experience
BEIJING, April 21, 2026 /PRNewswire/ -- CATL today hosted its Super Technology…
HCLTech FY26 revenue up 3.9%, led by increasing demand for Advanced AI
Annualized Advanced AI revenue at $620M; FY26 services revenue up 4.8% in…
/C O R R E C T I O N — Bybit/
In the news release, Bybit Uncovers AI-Assisted macOS Malware Campaign Targeting Users…
